United Kingdom· GB-APID-146411000001106
Periactin 4mg tablets
A cyproheptadine product containing cyproheptadine, registered in United Kingdom by Teva UK Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Cyproheptadine is registered in 10 of 19 countries.
Countries holding a registration under ATC R06AX02 (cyproheptadine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Cyproheptadine · ATC R06AX02
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Cyproheptadine
- Manufacturer
- Teva UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- R06AX02
- ATC class
- Cyproheptadine
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5013945113600
- gtin5060032242613
- gtin5017007600961
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
327 interactions on record for cyproheptadine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cyproheptadine · interactions on record
327 records
- 9 severe
- 316 moderate
- 2 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cyproheptadine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCyproheptadine HydrochlorideREMEDYREPACK INC.
- CzechiaPERITOLEgis Pharmaceuticals PLC, Budapešť
- NorwayCyproheptadine HClCypress Pharmaceutical
- CanadaJAMP-CYPROHEPTADINEJAMP PHARMA CORPORATION
- FrancePERIACTINE 4 mg, compriméTEOFARMA
- PolandPeritolEgis Pharmaceuticals PLC
- SpainPERIACTIN 4 MG COMPRIMIDOSAlfasigma Espana S.L.
- GermanyPeritolAbanta Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Czechia · Peritol
- Germany · Peritol
- Spain · Periactin
- France · Periactine
- Hungary · Peritol
- Italy · Periactin
- Poland · Peritol
- Portugal · Viternum
- Slovakia · Peritol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f43dbede-2fde-4ab9-a905-f43c14c45a6c GET /v1/drugs/f43dbede-2fde-4ab9-a905-f43c14c45a6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "146411000001106",
"desc": "Periactin 4mg tablets (Teva UK Ltd)",
"form": "Oral tablet",
"vpid": "42187511000001104",
"source": "dmd",
"vtm_id": "775426001",
"strength": "4 mg",
"substance": "Cyproheptadine",
"ingredient": "Cyproheptadine hydrochloride",
"supplier_code": "3849901000001105"
}See everything about cyproheptadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.